Covaxin safe, may be superior to similar vaccines: Lancet

India’s first indigenous Covid-19 vaccine Covaxin, codenamed BBV152, is safe, immunogenic and has no serious adverse effects, medical journal Lancet has said while publishing the vaccine’s phase 2 trial results.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/30wlLNw
via IFTTT